000 01394 a2200373 4500
005 20250517055314.0
264 0 _c20160701
008 201607s 0 0 eng d
022 _a1534-6269
024 7 _a10.1007/s11912-015-0479-4
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFankhauser, Christian Daniel
245 0 0 _aEmerging Therapeutic Targets for Male Germ Cell Tumors.
_h[electronic resource]
260 _bCurrent oncology reports
_cDec 2015
300 _a54 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aCisplatin
_xtherapeutic use
650 0 4 _aClinical Trials as Topic
650 0 4 _aHumans
650 0 4 _aImmunotherapy
_xmethods
650 0 4 _aMale
650 0 4 _aMolecular Targeted Therapy
_xmethods
650 0 4 _aNeoplasms, Germ Cell and Embryonal
_xdrug therapy
650 0 4 _aNeoplasms, Second Primary
_xdrug therapy
650 0 4 _aProtein Kinase Inhibitors
_xtherapeutic use
650 0 4 _aTesticular Neoplasms
_xdrug therapy
700 1 _aHonecker, Friedemann
700 1 _aBeyer, Jörg
700 1 _aBode, Peter Karl
773 0 _tCurrent oncology reports
_gvol. 17
_gno. 12
_gp. 54
856 4 0 _uhttps://doi.org/10.1007/s11912-015-0479-4
_zAvailable from publisher's website
999 _c25337481
_d25337481